Your browser is unsupported

We recommend using the latest version of IE11, Edge, Chrome, Firefox or Safari.

In this section


The monthly frequently asked questions are compiled by DIG faculty, residents, and students.  These summaries provide a concise overview of a current drug therapy topic.

Current - 2019 FAQs


Is there a role for newer cation exchange resins (ie, patiromer and sodium zirconium cyclosilicate) in the emergency management of hyperkalemia?

Update: What data are available to direct dosing of intravenous immunoglobulin G based on total versus ideal or adjusted body weight?

What evidence exists to support the use of nebulized sodium bicarbonate as a mucolytic in hospitalized patients?


What is the available literature regarding use of KCentra® (Four Factor Prothrombin Complex Concentrate) (4F-PCC) for the treatment of coagulopathies and acute hemorrhage in patients with liver disease who are not receiving concomitant anticoagulation therapy?

What data exist for the use of tolvaptan beyond 30 days in the setting of hyponatremia?

What are anesthesia safety considerations related to patients taking cannabis?


Can alteplase be used to clear occluded chest tubes?

What is the latest evidence on alternatives to magnesium sulfate in patients with preeclampsia and eclampsia?

What are the Infectious Diseases Society of America recommendations for the diagnosis and management of seasonal influenza?


What clinical data are available comparing nicardipine to clevidipine in acute ischemic stroke?

What evidence is available to support the use of N-acetylcysteine for impulse control disorders?

What evidence supports the use of direct-acting oral anticoagulants in patients with cancer-related VTE?